| Orchid Cove At Daytona | |
| 1001 S Beach Street, Daytona Beach, Florida 32114 | |
| (386) 258-3334 | |
| Name | Orchid Cove At Daytona |
|---|---|
| Location | 1001 S Beach Street, Daytona Beach, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 99 |
| Occupancy Rate | 78.99% |
| Medicare ID (CCN) | 105002 |
| Legal Business Name | Sandalwood Operating Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1619413572 |
| Organization Name | SANDALWOOD OPERATING LLC |
| Address | 1001 S Beach St, Daytona Beach, FL 32114 |
| Phone Number | 386-258-3334 |
News Archive
A new network of 25 regional stroke centers and satellite facilities - the NIH Stroke Trials Network - is working to change the way stroke research is conducted in the U.S. Despite advances of the last two decades, stroke remains a major public health problem.
Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.
More awareness about skin cancer is needed for minorities because they believe they are at low risk of developing it, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, has signed open access funding agreements with three European research organizations: the Max Planck Society in Germany, the FWF Austrian Science Fund, and Telethon, one of the largest biomedical non-profit organizations in Italy.
› Verified 6 days ago
| NPI Number | 1952936742 |
| Organization Name | DAYTONA BEACH FL OPCO LLC |
| Doing Business As | BEACH STREET HEALTH AND REHABILITATION CENTER |
| Address | 1001 S Beach St, Daytona Beach, FL 32114 |
| Phone Number | 386-258-3334 |
News Archive
A new network of 25 regional stroke centers and satellite facilities - the NIH Stroke Trials Network - is working to change the way stroke research is conducted in the U.S. Despite advances of the last two decades, stroke remains a major public health problem.
Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.
More awareness about skin cancer is needed for minorities because they believe they are at low risk of developing it, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, has signed open access funding agreements with three European research organizations: the Max Planck Society in Germany, the FWF Austrian Science Fund, and Telethon, one of the largest biomedical non-profit organizations in Italy.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new network of 25 regional stroke centers and satellite facilities - the NIH Stroke Trials Network - is working to change the way stroke research is conducted in the U.S. Despite advances of the last two decades, stroke remains a major public health problem.
Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.
More awareness about skin cancer is needed for minorities because they believe they are at low risk of developing it, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, has signed open access funding agreements with three European research organizations: the Max Planck Society in Germany, the FWF Austrian Science Fund, and Telethon, one of the largest biomedical non-profit organizations in Italy.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.38 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.92 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.88 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.28 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.35 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.68 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.76 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 89.71 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.48 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.72 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.7 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.33 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.12 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.89 | 82.93 |
News Archive
A new network of 25 regional stroke centers and satellite facilities - the NIH Stroke Trials Network - is working to change the way stroke research is conducted in the U.S. Despite advances of the last two decades, stroke remains a major public health problem.
Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.
More awareness about skin cancer is needed for minorities because they believe they are at low risk of developing it, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, has signed open access funding agreements with three European research organizations: the Max Planck Society in Germany, the FWF Austrian Science Fund, and Telethon, one of the largest biomedical non-profit organizations in Italy.
› Verified 6 days ago
Orchid Cove At Daytona Location: 1001 S Beach Street, Daytona Beach, Florida 32114 Phone: (386) 258-3334 | |
Seaside Health And Rehabilitation Center Location: 324 Wilder Blvd, Daytona Beach, Florida 32114 Phone: (386) 252-2600 | |
Daytona Beach Health And Rehabilitation Center Location: 1055 3rd Street, Daytona Beach, Florida 32117 Phone: (386) 252-3686 | |
Coastal Health And Rehabilitation Center Location: 820 N Clyde Morris Blvd, Daytona Beach, Florida 32117 Phone: (386) 274-4575 | |
Carlton Shores Health And Rehabilitation Center Location: 1350 S Nova Rd, Daytona Beach, Florida 32114 Phone: (386) 258-5544 |